Fig. 6From: Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancerComparison of the positivity rate of the different imaging modalities after classification of patients in groups based on their PSA plasma levels. Patients were separated in four groups: Group A, PSA ≤0.2 ng/ml; Group B, PSA > 0.2 and ≤ 0.5 ng/ml; Group C, PSA > 0.5 and ≤ 2.0 ng/ml; Group D, PSA > 2.0 ng/ml. A statistically significant increase in the positivity rate in all imaging modalities (PET-CT, PET-MRI, MRI) with increasing PSA levels is observed (A, B, C)Back to article page